UNICK FIX-A-FORM AND PRINTERS | KREBS BIOCHEMICALS | UNICK FIX-A-FORM AND PRINTERS/ KREBS BIOCHEMICALS |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 27.9 | -7.6 | - | View Chart |
P/BV | x | 1.1 | - | - | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
UNICK FIX-A-FORM AND PRINTERS KREBS BIOCHEMICALS |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
UNICK FIX-A-FORM AND PRINTERS Mar-23 |
KREBS BIOCHEMICALS Mar-23 |
UNICK FIX-A-FORM AND PRINTERS/ KREBS BIOCHEMICALS |
5-Yr Chart Click to enlarge
|
||
High | Rs | 59 | 190 | 31.1% | |
Low | Rs | 32 | 51 | 61.6% | |
Sales per share (Unadj.) | Rs | 120.5 | 24.2 | 498.5% | |
Earnings per share (Unadj.) | Rs | 4.1 | -11.5 | -35.6% | |
Cash flow per share (Unadj.) | Rs | 11.2 | -8.4 | -133.4% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | 53.9 | -46.1 | -116.8% | |
Shares outstanding (eoy) | m | 5.49 | 21.56 | 25.5% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0.4 | 5.0 | 7.5% | |
Avg P/E ratio | x | 11.1 | -10.5 | -105.3% | |
P/CF ratio (eoy) | x | 4.0 | -14.3 | -28.1% | |
Price / Book Value ratio | x | 0.8 | -2.6 | -32.1% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 248 | 2,599 | 9.6% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 90 | 155 | 57.8% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 662 | 521 | 126.9% | |
Other income | Rs m | 5 | 6 | 82.4% | |
Total revenues | Rs m | 667 | 528 | 126.4% | |
Gross profit | Rs m | 88 | -158 | -55.6% | |
Depreciation | Rs m | 39 | 66 | 59.7% | |
Interest | Rs m | 24 | 30 | 80.1% | |
Profit before tax | Rs m | 30 | -247 | -12.1% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 7 | 0 | - | |
Profit after tax | Rs m | 22 | -247 | -9.1% | |
Gross profit margin | % | 13.3 | -30.3 | -43.8% | |
Effective tax rate | % | 25.0 | 0 | - | |
Net profit margin | % | 3.4 | -47.4 | -7.2% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 301 | 161 | 187.4% | |
Current liabilities | Rs m | 287 | 491 | 58.4% | |
Net working cap to sales | % | 2.1 | -63.4 | -3.3% | |
Current ratio | x | 1.0 | 0.3 | 320.7% | |
Inventory Days | Days | 4 | 53 | 7.3% | |
Debtors Days | Days | 72,349,839 | 37 | 196,761,913.1% | |
Net fixed assets | Rs m | 402 | 1,589 | 25.3% | |
Share capital | Rs m | 55 | 216 | 25.4% | |
"Free" reserves | Rs m | 241 | -1,210 | -19.9% | |
Net worth | Rs m | 296 | -995 | -29.8% | |
Long term debt | Rs m | 89 | 1,732 | 5.1% | |
Total assets | Rs m | 705 | 1,750 | 40.3% | |
Interest coverage | x | 2.3 | -7.3 | -30.9% | |
Debt to equity ratio | x | 0.3 | -1.7 | -17.2% | |
Sales to assets ratio | x | 0.9 | 0.3 | 314.8% | |
Return on assets | % | 6.6 | -12.4 | -52.8% | |
Return on equity | % | 7.6 | 24.8 | 30.5% | |
Return on capital | % | 14.0 | -29.4 | -47.4% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 0 | - | |
Fx outflow | Rs m | 0 | 5 | 0.0% | |
Net fx | Rs m | 0 | -5 | -0.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 44 | -247 | -17.7% | |
From Investments | Rs m | -27 | -126 | 21.4% | |
From Financial Activity | Rs m | -16 | 373 | -4.4% | |
Net Cashflow | Rs m | 0 | 0 | -233.3% |
Indian Promoters | % | 71.6 | 72.7 | 98.4% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.5 | 0.5 | 90.0% | |
FIIs | % | 0.0 | 0.5 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 28.4 | 27.3 | 104.3% | |
Shareholders | 1,622 | 8,909 | 18.2% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare UNICK FIX-A-FORM AND PRINTERS With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | UNICK FIX-A-FORM AND PRINTERS | KREBS BIOCHEMICALS | S&P BSE TECK |
---|---|---|---|
1-Day | 4.56% | 2.61% | -0.26% |
1-Month | 21.23% | 9.84% | -0.74% |
1-Year | 56.84% | -2.33% | 29.95% |
3-Year CAGR | 31.01% | -19.09% | 10.57% |
5-Year CAGR | 20.58% | -5.46% | 15.11% |
* Compound Annual Growth Rate
Here are more details on the UNICK FIX-A-FORM AND PRINTERS share price and the KREBS BIOCHEMICALS share price.
Moving on to shareholding structures...
The promoters of UNICK FIX-A-FORM AND PRINTERS hold a 71.6% stake in the company. In case of KREBS BIOCHEMICALS the stake stands at 72.7%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of UNICK FIX-A-FORM AND PRINTERS and the shareholding pattern of KREBS BIOCHEMICALS.
Finally, a word on dividends...
In the most recent financial year, UNICK FIX-A-FORM AND PRINTERS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.
KREBS BIOCHEMICALS paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of UNICK FIX-A-FORM AND PRINTERS, and the dividend history of KREBS BIOCHEMICALS.
For a sector overview, read our media sector report.
Indian share markets reversed the trend as the session progressed and ended the lower. After starting higher on Friday, equity markets had an anti-climatic end today.